Completed PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT01390077

Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria

Sponsor: University of California, San Diego

Interventions Nitisinone

Updated 9 times since 2017 Last updated: Mar 23, 2021 Started: Jan 31, 2011 Primary completion: Jun 30, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Alkaptonuria and is currently completed. University of California, San Diego leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2_PHASE3
May 2021 — Dec 2022 [monthly]

Completed PHASE2_PHASE3

Status: Unknown Status → Completed

▶ Show 4 earlier versions

Jan 2021 — May 2021 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

Status: Active Not Recruiting → Unknown Status
Feb 2017 — Jun 2018 [monthly]

Active Not Recruiting PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting PHASE2_PHASE3

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Diego

Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• La Jolla, United States